{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:17:28Z","timestamp":1768551448569,"version":"3.49.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p\/>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Preoperative intravenous epoprostenol therapy can cause thrombocytopaenia, which may increase the risk of perioperative bleeding during lung transplantation. This study aimed to determine whether lung transplantation can be safely performed in patients with epoprostenol-induced thrombocytopaenia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>From June 2008 to July 2022, we performed 37 lung transplants in patients with pulmonary arterial hypertension (PAH), including idiopathic PAH (n\u2009=\u200926), congenital heart disease-associated PAH (n\u2009=\u20097), pulmonary veno-occlusive disease (n\u2009=\u20093) and peripheral pulmonary artery stenosis (n\u2009=\u20091) at our institution. Of these, 26 patients received intravenous epoprostenol therapy (EPO group), whereas 11 patients were treated with no epoprostenol (no-EPO group). We retrospectively analysed the preoperative and postoperative platelet counts and post-transplant outcomes in each group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Preoperative platelet counts were relatively lower in the EPO group than in the no-EPO group (median EPO: 127\u00a0000 vs no-EPO: 176\u00a0000\/\u03bcl). However, blood loss during surgery was similar between the 2 groups (EPO: 2473\u2009ml vs no-EPO: 2615\u2009ml). The platelet counts significantly increased over 1 month after surgery, and both groups showed similar platelet counts (EPO: 298\u00a0000 vs no-EPO: 284\u00a0000\/\u03bcl). In-hospital mortality (EPO: 3.9% vs no-EPO: 18.2%) and the 3-year survival rate (EPO: 91.4% vs no-EPO: 80.8%) were similar between the 2 groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Patients with PAH treated with intravenous epoprostenol showed relatively lower platelet counts, which improved after lung transplantation with good post-transplant outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezae108","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T04:14:18Z","timestamp":1711599258000},"source":"Crossref","is-referenced-by-count":2,"title":["Effect of epoprostenol-induced thrombocytopaenia on lung transplantation for pulmonary arterial hypertension"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0847-4812","authenticated-orcid":false,"given":"Naoki","family":"Date","sequence":"first","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0789-2350","authenticated-orcid":false,"given":"Satona","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7659-8067","authenticated-orcid":false,"given":"Yoshito","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4220-969X","authenticated-orcid":false,"given":"Yojiro","family":"Yutaka","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-8260","authenticated-orcid":false,"given":"Masatsugu","family":"Hamaji","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-6002","authenticated-orcid":false,"given":"Toshi","family":"Menju","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2847-9653","authenticated-orcid":false,"given":"Akihiro","family":"Ohsumi","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7262-6000","authenticated-orcid":false,"given":"Hiroshi","family":"Date","sequence":"additional","affiliation":[{"name":"Department of Thoracic surgery, Kyoto University Graduate School of Medicine , Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"2024033010591435400_ezae108-B1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"2024033010591435400_ezae108-B2","doi-asserted-by":"crossref","first-page":"160055","DOI":"10.1183\/16000617.0055-2016","article-title":"Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience","volume":"26","author":"Sitbon","year":"2017","journal-title":"Eur Respir Rev"},{"key":"2024033010591435400_ezae108-B3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1378\/chest.08-1323","article-title":"Hemodynamics and epoprostenol use are associated with thrombocytopaenia in pulmonary arterial hypertension","volume":"135","author":"Chin","year":"2009","journal-title":"Chest"},{"key":"2024033010591435400_ezae108-B4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11748-021-01746-7","article-title":"New strategy to resume and taper epoprostenol after lung transplant for pulmonary hypertension","volume":"70","author":"Ohsumi","year":"2022","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2024033010591435400_ezae108-B5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"2024033010591435400_ezae108-B6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.31083\/j.rcm.2020.02.597","article-title":"Current and emerging therapeutic approaches to pulmonary hypertension","volume":"21","author":"Bisserier","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"2024033010591435400_ezae108-B7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"2024033010591435400_ezae108-B8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1536\/ihj.16-389","article-title":"High frequency of acute adverse cardiovascular events after lung transplantation in patients with pulmonary arterial hypertension receiving preoperative long-term intravenous prostacyclin","volume":"58","author":"Akagi","year":"2017","journal-title":"Int Heart J"},{"key":"2024033010591435400_ezae108-B9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archinte.1991.00400060133023","article-title":"Primary pulmonary hypertension. Its association with microangiopathic hemolytic anemia and thrombocytopaenia","volume":"151","author":"Jubelirer","year":"1991","journal-title":"Arch Intern Med"},{"key":"2024033010591435400_ezae108-B10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.amjcard.2023.08.078","article-title":"Transition from intravenous epoprostenol to treprostinil due to intolerable side effects in patients with pulmonary arterial hypertension","volume":"206","author":"Kikuchi","year":"2023","journal-title":"Am J Cardiol"},{"key":"2024033010591435400_ezae108-B11","doi-asserted-by":"crossref","first-page":"2045894020969103","DOI":"10.1177\/2045894020969103","article-title":"Severe thrombocytopaenia in patients with idiopathic pulmonary arterial hypertension provided several strategies for lung transplantation","volume":"10","author":"Kobayashi","year":"2020","journal-title":"Pulm Circ"},{"key":"2024033010591435400_ezae108-B12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.tips.2017.03.003","article-title":"Targeting the prostacyclin pathway: beyond pulmonary arterial hypertension","volume":"38","author":"Pluchart","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"2024033010591435400_ezae108-B13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.thromres.2015.05.027","article-title":"Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease","volume":"136","author":"Friedman","year":"2015","journal-title":"Thromb Res"},{"key":"2024033010591435400_ezae108-B14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bja.2018.09.010","article-title":"Perioperative thrombocytopaenia: evidence, evaluation, and emerging therapies","volume":"122","author":"Nagrebetsky","year":"2019","journal-title":"Br J Anaesth"},{"key":"2024033010591435400_ezae108-B15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopaenia (HIT): review of incidence, diagnosis, and management","volume":"25","author":"Hogan","year":"2020","journal-title":"Vasc Med"},{"key":"2024033010591435400_ezae108-B16","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.ijcard.2013.07.072","article-title":"Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease","volume":"168","author":"Thomas","year":"2013","journal-title":"Int J Cardiol"},{"key":"2024033010591435400_ezae108-B17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ejcts\/ezx212","article-title":"Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome","volume":"53","author":"Moser","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024033010591435400_ezae108-B18","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.jtcvs.2014.07.061","article-title":"Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation","volume":"148","author":"Biscotti","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024033010591435400_ezae108-B19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jtcvs.2022.06.024","article-title":"The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: the use of mechanical circulatory support in lung transplantation","volume":"165","author":"Hartwig","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024033010591435400_ezae108-B20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chest.2023.04.047","article-title":"Lung transplantation for pulmonary arterial hypertension","volume":"164","author":"Kolaitis","year":"2023","journal-title":"Chest"},{"key":"2024033010591435400_ezae108-B21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jacc.2007.03.054","article-title":"Living-donor lobar lung transplantation for pulmonary arterial hypertension after failure of epoprostenol therapy","volume":"50","author":"Date","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2024033010591435400_ezae108-B22","doi-asserted-by":"crossref","first-page":"ezad024","DOI":"10.1093\/ejcts\/ezad024","article-title":"Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension","volume":"63","author":"Kayawake","year":"2023","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezae108\/57105675\/ezae108.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/65\/4\/ezae108\/57124120\/ezae108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/65\/4\/ezae108\/57124120\/ezae108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T10:59:30Z","timestamp":1711796370000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezae108\/7636467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,3,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezae108","relation":{},"ISSN":["1873-734X"],"issn-type":[{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,3,27]]},"article-number":"ezae108"}}